* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Shenzhenlubris Pharmaceuticals Co Gross Profit Chart
Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's Gross Profit
For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhenlubris Pharmaceuticals Co's Gross Profit Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's Gross Profit distribution charts can be found below:
* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's Gross Profit falls into.
Shenzhenlubris Pharmaceuticals Co Gross Profit Calculation
Gross Profit is the different between the sale prices and the cost of buying or producing the goods.
Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,458 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Gross Profit Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Shenzhenlubris Pharmaceuticals Co had a gross margin of 71.45% for the quarter that ended in Mar. 2024 => Durable competitive advantage
Shenzhenlubris Pharmaceuticals Co Gross Profit Related Terms
Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.
Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:002294 has been successfully added to your 